Zhengye Biotechnology Holding (ZYBT) Income Statement: Revenue & Earnings

Zhengye Biotechnology Holding Income Statement Analysis

Revenue, earnings, and profit margins in millions CNY

Scale:

Scroll to see more

Zhengye Biotechnology Holding Limited income statement - Annual data in millions CNY
Breakdown	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	186.36	186.36	211.65	260.27	214.07
Cost of Revenue	95.06	95.06	94.14	112.39	88.67
Gross Profit	91.30	91.30	117.51	147.88	125.39
Operating Expenses
Research & Development	12.79	12.79	11.90	13.42	11.37
Selling, General & Administrative	63.84	63.84	64.34	58.89	58.19
Operating Expenses	74.86	74.86	69.87	82.05	69.79
Operating Income	16.44	16.44	47.64	65.83	55.61
Other Income/Expense
Interest Income	0.23	0.23	0.31	0.11	0.11
Interest Expense	4.04	-4.04	4.42	-2.84	1.05
Other Income/Expense	-2.05	1.09	0.23	0.81	-1.61
Income
Income Before Tax	14.39	14.39	43.76	63.91	53.07
Income Tax Expense	0.92	0.92	6.25	8.17	6.60
Net Income	11.31	11.31	31.46	46.74	38.96
Net Income - Continuous Operations	11.31	13.47	37.51	55.74	46.47
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	42.60	40.60	72.10	84.63	70.12
EBIT	0.00	16.44	48.19	65.83	54.11
Depreciation & Amortization	24.16	24.16	23.91	18.80	16.01
Earnings Per Share
Basic EPS	-	-	1.00	1.00	1.00
Diluted EPS	-	-	1.00	1.00	1.00
Basic Shares Outstanding	0.00	45.67	45.67	45.67	45.67
Diluted Shares Outstanding	0.00	45.67	47.17	45.67	47.17